Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 21;11(1):2054105. doi: 10.1080/2162402X.2022.2054105

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 5. — STING agonist cGAMP enhanced the therapeutic effect of anti-MSLN CAR-NK-92 cells on pancreatic cancer. (a) Diagram depicting the treatment schedule of STING agonist in combination with anti-MSLN CAR-NK cells in subcutaneous (s.c.) pancreatic tumors of NOD-SCID mice, blue arrows indicate cGAMP treatment, red arrow indicates NK-92 cells or CAR-NK-92 cells treatment, and green arrow indicates IL-2 treatment. (b) Tumor volume was measured with vernier calipers every two or three days. (c) The Violin diagram showing tumors volume measured on day 31. (d) Survival analyses of tumor-bearing mice treated with the indicated control and experimental groups, and were analyzed using Log-rank (Mantel-Cox) test. The statistical significance was determined as ***p < .001, **p < .01 and *p < .05.